A recent study reported the decreased expression levels of miR-19b in patients with PCOS, where miR-19b targets insulin-like growth factor 1 (IGF-1) to promote the proliferation of granulosa cells [17]. This evidence concerns the gene IGF1 and polycystic ovary syndrome.